This story in the Wall Street Journal barely made a splash last week – “FDA Panelists Had Ties to Bayer.” Three advisors who had financial ties to Bayer AG were invited to serve on a “safety committee” for the FDA to assess the safety of four Bayer AG birth control drugs. All three individuals were either paid consultants, researchers, or speakers.
No comments:
Post a Comment